Evidence map›Paper›PMID 35636828›Full record

ReviewClinics in laboratory medicine2022

Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

Kyle G Rodino, Kenneth P Smith, Matthew A Pettengill

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinics in laboratory medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kyle G RodinoDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 4th Floor Gates Building, Philadelphia, PA 19104, USA; Clinical Microbiology Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: https://twitter.com/KGRodinoPhD.
Kenneth P SmithPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Infectious Disease Diagnostics Laboratory, Children's Hospital of Philadelphia, Main Building 5NW91, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Matthew A PettengillDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, 117 South 11th Street, Pavilion Building, Suite 207, Philadelphia, PA 19107-4998, USA. Electronic address: matthew.pettengill@jefferson.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From the onset of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 pandemic, there has been a major emphasis on molecular laboratory tests for the virus. Shortages in various testing supplies, the desire to increase testing capacity, and a push to make point-of-care or home-based testing available have fostered considerable innovation for SARS-CoV-2 molecular diagnostics, advancements likely to be applicable to other diagnostic uses. The authors attempt to cover some of the most compelling novel types of molecular assays or novel approaches in adapting established molecular methodologies for SARS-CoV-2 detection or characterization.

Indexed as

COVID-19SARS-CoV-2HumansPandemicsCOVID-19CRISPR-CasMicrofluidicsMolecularNext-generation sequencingSARS-CoV-2Variant

Identifiers

PMID35636828
PMCPMC8904158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.